Development, estimation and validation of oseltamivir in bulk and in its pharmaceutical formulation by UV-VIS spectroscopic method

INIS

• pharmaceuticals 100%
• drugs 100%
• validation 100%
• viruses 100%
• conferences 50%
• host 50%
• range 50%
• absorption 50%
• guidelines 50%
• solvents 50%
• influenza 50%
• quality control 50%
• interference 50%
• capsules 50%
• sodium hydroxides 50%
• cutting 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Oseltamivir 100%
• Influenza 40%
• Dosage Forms 40%
• Virus 40%
• Drug 20%
• Solvent 20%
• Excipient 20%
• Antivirus Agent 20%
• Capsule 20%
• Host 20%
• Sialidase Inhibitor 20%